Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

Episurf Medical

0,03 SEK

+1,77 %

Mindre end 1K følgere

EPIS B

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Oversigt
Finansielt overblik og estimater
Ejerskab
Investorkonsensus
Sammenligne
+1,77 %
-4,97 %
-38,68 %
-61,56 %
-69,20 %
-70,33 %
-97,41 %
-97,64 %
-99,21 %

Episurf Medical operates in the medical technology industry and focuses on the development and manufacture of individually adapted implants for joint repair. The company's products are aimed at surgeons and healthcare institutions. The business is global with a main presence in Europe, North America and Asia. Episurf Medical was founded in 2008 and is headquartered in Stockholm, Sweden.

Læs mere
Markedsværdi
47,64 mio. SEK
Aktieomsætning
85,12 t SEK
Omsætning
13 mio.
EBIT %
-593,85 %
P/E
-
Udbytteafkast, %
-
Omsætning og EBIT-margin

Omsætning mio.

EBIT-% (adj.)

EPS og udbytte

EPS (adj.)

Udbytte %

Finanskalender
6.2
2026

Årsrapport '25

10.4
2026

Generalforsamling '26

24.4
2026

Delårsrapport Q1'26

Alle
Selskabsmeddelelser
Eksterne analyser
ViserAlle indholdstyper
Pressemeddelelse18.11.2025, 10.45

Update on Episurf Medical's MTP implant

Episurf Medical
Pressemeddelelse4.11.2025, 07.45

Episurf's implants market approved in Singapore

Episurf Medical
Selskabsmeddelelse2.11.2025, 20.30

Board Member Resigns from the Board of Episurf Medical

Episurf Medical

Bliv en del af Inderes community

Gå ikke glip af noget - opret en konto og få alle de mulige fordele

Inderes konto
Følgere og notifikationer om fulgte virksomheder
Analytikerkommentarer og anbefalinger
Værktøj til at sammenligne aktier og andre populære værktøjer
Opret konto
Pressemeddelelse27.10.2025, 13.20

Redeye: Episurf Medical (Q3 review) - Growing the US customer base

Episurf Medical
Selskabsmeddelelse24.10.2025, 06.30

Episurf: Interim Report 1 January - 30 September 2025

Episurf Medical
Pressemeddelelse17.10.2025, 06.45

Episurf: Scientific article on Episealer® Knee with up to 10 years' follow-up published

Episurf Medical
Pressemeddelelse12.10.2025, 20.00

Board Member Resigns from the Board of Episurf Medical

Episurf Medical
Selskabsmeddelelse30.9.2025, 10.15

Change in number of shares and votes in Episurf Medical

Episurf Medical
Selskabsmeddelelse16.9.2025, 15.40

New Chief Executive Officer at Episurf Medical

Episurf Medical
Pressemeddelelse1.9.2025, 06.00

Episurf: Episealer® included in the Swedish Knee Arthroplasty Register 2025

Episurf Medical
Selskabsmeddelelse29.8.2025, 06.00

Episurf Medical AB changes liquidity provider to Mangold Fondkommission AB

Episurf Medical
Pressemeddelelse28.8.2025, 18.30

Episurf Medical resolves on an issue of units to guarantors in connection with the completed rights issue

Episurf Medical
Pressemeddelelse25.8.2025, 18.30

Episurf Medical announces final outcome of the rights issue

Episurf Medical
Selskabsmeddelelse22.8.2025, 15.40

Episurf: Preliminary outcome indicates significantly oversubscribed rights issue

Episurf Medical
Pressemeddelelse20.8.2025, 15.30

Episurf Medical announces interview with CEO

Episurf Medical
Selskabsmeddelelse5.8.2025, 10.00

Episurf Medical publishes prospectus in connection with the company's rights issue of units

Episurf Medical
Selskabsmeddelelse4.8.2025, 13.15

Summary from the Extraordinary General Meeting of Episurf Medical AB (publ)

Episurf Medical
Selskabsmeddelelse1.8.2025, 06.00

The Swedish Securities Council grants exemption from the obligation to submit a mandatory offer in connection with Episurf Medical's rights issue of units

Episurf Medical
Pressemeddelelse15.7.2025, 10.13

Redeye: Episurf Medical Q2 2025 - Negative impact due to ongoing restructuring

Episurf Medical
Selskabsmeddelelse11.7.2025, 06.30

Episurf: Interim Report 1 January - 30 June 2025

Episurf Medical
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.